ATC Group: D10AD01 Tretinoin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D10AD01 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D10 Anti-acne preparations
3 D10A Anti-acne preparations for topical use
4 D10AD Retinoids for topical use in acne
5 D10AD01 Tretinoin

Active ingredients in D10AD01

Active Ingredient Description
Tretinoin

Tretinoin decreases cohesiveness of follicular epithelial cells resulting in decreased microcomedone formation. Additionally, tretinoin stimulates mitotic activity and increased turnover of follicular epithelial cells, causing extrusion of the comedones.

Related product monographs

Title Information Source Document Type  
RETIN-A Cream / Gel FDA, National Drug Code (US) MPI, US: SPL/Old
STIEVA-A Cream Health Products and Food Branch (CA) MPI, CA: SPM

Medicines in this ATC group

United States (US)

Brazil (BR)

Canada (CA)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Germany (DE)

Hong Kong (HK)

Israel (IL)

Japan (JP)

Malta (MT)

Mexico (MX)

New Zealand (NZ)

Poland (PL)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.